Comprehensive assessment of recessive, pathogenic AARS1 alleles in a humanized yeast model reveals loss-of-function and dominant-negative effects

Molly E Kuo,Maclaine Parish,Kira E Jonatzke,Anthony Antonellis

DOI: https://doi.org/10.1101/2024.06.20.599900

2024-06-24

Abstract:Alanyl-tRNA synthetase 1 (AARS1) encodes the enzyme that ligates tRNA molecules to alanine in the cytoplasm, which is required for protein translation. Variants in AARS1 have been implicated in early-onset, multi-system recessive phenotypes and in later-onset dominant peripheral neuropathy; to date, no single variant has been associated with both dominant and recessive diseases raising questions about shared mechanisms between the two inheritance patterns. AARS1 variants associated with recessive disease are predicted to result in null or hypomorphic alleles and this has been demonstrated, in part, via yeast complementation assays. However, pathogenic alleles have not been assessed in a side-by-side manner to carefully scrutinize the strengths and limitations of this model system. To address this, we employed a humanized yeast model to evaluate the functional consequences of all AARS1 missense variants reported in recessive disease. The majority of variants showed variable loss-of-function effects, ranging from no growth to significantly reduced growth. These data deem yeast a reliable model to test the functional consequences of human AARS1 variants; however, our data indicate that this model is prone to false-negative results and is not informative for genotype-phenotype studies. We next tested missense variants associated with no growth for dominant-negative effects. Interestingly, K81T AARS1, a variant implicated in recessive disease, demonstrated loss-of-function and dominant-negative effects, indicating that certain AARS1 variants may be capable of causing both dominant and recessive disease phenotypes.

Genetics

What problem does this paper attempt to address?

The paper attempts to address the following issues: 1. **Evaluation of recessive pathogenic variants of the AARS1 gene**: The paper comprehensively assesses the functional effects of AARS1 gene variants associated with recessive genetic diseases by constructing a humanized yeast model. The study finds that these variants exhibit varying degrees of loss-of-function effects in yeast. 2. **Exploration of loss-of-function and dominant-negative effects**: The study finds that certain AARS1 variants not only lead to loss-of-function but also exhibit dominant-negative effects. Specifically, the K81T variant shows both loss-of-function and dominant-negative effects in the yeast model. 3. **Comparison of different detection methods**: The paper compares the effectiveness of various functional detection methods, including RNA expression studies, Western blot analysis, in vitro aminoacylation assays, and yeast complementation assays, to evaluate their ability to detect loss-of-function effects. 4. **Revealing the limitations of genotype-phenotype relationships**: The study points out that while the yeast model can detect loss-of-function effects, it has some limitations, such as the inability to detect subtle functional defects and to explain the relationship between genotype and phenotype. 5. **Exploration of the mechanisms of recessive and dominant genetic diseases**: The results suggest that some AARS1 variants that cause recessive genetic diseases may also have dominant-negative effects, indicating that individuals carrying these variants may exhibit dominant axonal neuropathy symptoms. This helps in understanding the heterogeneity and mechanisms of AARS1-related genetic diseases.

Comprehensive assessment of recessive, pathogenic AARS1 alleles in a humanized yeast model reveals loss-of-function and dominant-negative effects

A humanized yeast model reveals dominant-negative properties of neuropathy-associated alanyl-tRNA synthetase mutations

A model organism pipeline provides insight into the clinical heterogeneity of TARS1 loss-of-function variants

Predictive modeling provides insight into the clinical heterogeneity associated with loss-of-function mutations

A missense, loss-of-function YARS1 variant in a patient with proximal-predominant motor neuropathy

Hearing impairment-associated KARS mutations lead to defects in aminoacylation of both cytoplasmic and mitochondrial tRNA Lys

Investigation in yeast of novel variants in mitochondrial aminoacyl-tRNA synthetases WARS2, NARS2, and RARS2 genes associated with mitochondrial diseases

Emerging mechanisms of aminoacyl-tRNA synthetase mutations in recessive and dominant human disease

Alanyl-tRNA Synthetase 1 Gene Variants in Hereditary Neuropathy: Genotype and Phenotype Overview

Mitochondrial Aminoacyl-tRNA Synthetase and Disease: The Yeast Contribution for Functional Analysis of Novel Variants

Dominant aminoacyl-tRNA synthetase disorders: lessons learned from in vivo disease models

A Humanized Yeast Model for Studying TRAPP Complex Mutations; Proof-of-Concept Using Variants from an Individual with a TRAPPC1-Associated Neurodevelopmental Syndrome

Drosophila Models for Charcot–Marie–Tooth Neuropathy Related to Aminoacyl-tRNA Synthetases

A yeast based assay establishes the pathogenicity of novel missense ACTA2 variants associated with aortic aneurysms

Hearing impairment-associated KARS mutations lead to defects in aminoacylation of both cytoplasmic and mitochondrial tRNALys

A yeast-based complementation assay elucidates the functional impact of 200 missense variants in human PSAT1

Clinical characteristics and proteome modifications in two Charcot-Marie-Tooth families with the AARS1 Arg326Trp mutation

Alanyl-tRNA synthetase 1 (AARS1) gene mutation in a family with intermediate Charcot-Marie-Tooth neuropathy

Mitochondrial aminoacyl-tRNA synthetases trigger unique compensatory mechanisms in neurons

Case Report: A new case of YARS1-associated autosomal recessive disorder with compound heterozygous and concurrent 47, XXY

Neuropathy‐associated histidyl‐tRNA synthetase variants attenuate protein synthesis in vitro and disrupt axon outgrowth in developing zebrafish